Rigel Pharmaceuticals recently disclosed the issuance of inducement grants in accordance with NASDAQ Listing Rule 5635(c)(4). This announcement comes as StockTitan reported on the news.
Rigel Pharmaceuticals recently disclosed the issuance of inducement grants in accordance with NASDAQ Listing Rule 5635(c)(4). This announcement comes as StockTitan reported on the news.